Novanta Inc. NOVT R2K
Company Overview
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.22.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $980.60M (+3.3% YoY); net profit $53.83M.
- Trailing 12 Months Year-on-year growth — revenue +10.4%, earnings -13.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 8.8%, profit CAGR 3.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 8.80% |
| 1 Year: | 10.40% |
Compounded Profit Growth
| 5 Years: | 3.87% |
| 1 Year: | -13.40% |
Stock Price Performance
| 1 Year: | +15.80% |
| 6 Months: | +11.97% |
| 3 Months: | +13.99% |
| 1 Month: | -9.72% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)42.57 · Neutral
P/E of 104.73 is above the sector median of 36.02 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 104.7.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NOVT Novanta Inc. R2K | 146.62 | 104.73 | $5.22B | 0.00% | 5.90% | 5.16% | 8.80% | 3.87% |
| 2 | NVDA NVIDIA Corporation NDXSPXAI | 211.80 | 32.43 | $5.13T | 0.49% | 74.66% | 114.29% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPX | 314.86 | 38.07 | $4.62T | 0.37% | 68.72% | 141.47% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXAI | 384.93 | 22.91 | $2.86T | 0.93% | 26.90% | 34.01% | 9.48% | 10.85% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AI | 420.39 | 36.18 | $2.18T | 0.90% | 30.20% | 36.21% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXAI | 389.11 | 64.85 | $1.85T | 0.68% | 16.70% | 37.28% | 24.38% | 26.24% |
| 7 | MU Micron Technology, Inc. NDXSPXAI | 983.12 | 46.37 | $1.11T | 0.06% | 13.69% | 39.82% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXAI | 548.13 | 181.50 | $893.78B | 0.00% | 6.33% | 8.06% | 13.64% | 48.64% |
| 9 | ASML ASML Holding N.V. NDXAI | 1,775.64 | 59.55 | $684.36B | 0.47% | 42.97% | 52.24% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Apr 2015 | Jul 2015 | Oct 2015 | Dec 2015 | Apr 2016 | Jul 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Apr 2020 | Jul 2020 | Oct 2020 | Apr 2021 | Jul 2021 | Oct 2021 | Apr 2022 | Jul 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 119.10M | 146.30M | 146.97M | 150.40M | 160.79M | 157.19M | 155.15M | 154.07M | 155.47M | 144.73M | 142.93M | 162.58M | 167.52M | 177.73M | 204.22M | 215.36M | 222.96M | 219.13M | 229.46M | 221.50M | 230.92M | 235.86M | 244.41M | 233.37M | 241.05M | 247.84M | 257.71M |
| Gross Profit | 34.20M | 32.10M | 38.65M | 39.68M | 39.73M | 40.01M | 41.34M | 39.91M | 36.63M | 36.89M | 41.50M | 41.21M | 46.09M | 53.49M | 58.71M | 62.16M | 65.23M | 69.63M | 66.29M | 65.78M | 64.05M | 64.44M | 58.70M | 59.10M | 68.74M | 72.41M | 76.30M | 90.28M | 95.25M | 98.41M | 97.63M | 104.12M | 101.59M | 100.42M | 103.69M | 109.22M | 104.35M | 106.75M | 110.92M | 113.58M |
| Operating Income | 6.79M | 4.07M | 6.48M | 6.82M | -34.18M | 5.40M | 10.31M | 9.01M | 4.21M | 2.59M | 7.60M | 11.05M | 10.34M | 15.75M | 12.41M | 17.23M | 17.11M | 21.00M | 14.39M | 15.11M | 12.80M | 13.25M | 13.70M | 11.87M | 11.10M | 15.99M | 15.28M | 24.28M | 23.29M | 28.66M | 26.31M | 32.20M | 30.31M | 25.61M | 25.71M | 32.55M | 32.42M | 14.91M | 21.85M | 27.54M |
| Net Income | 4.31M | 983.00K | 725.00K | 4.53M | -30.48M | 3.45M | 19.50M | 6.57M | - | 1.91M | 4.87M | 7.47M | 34.25M | 9.40M | 7.53M | 11.91M | 11.00M | 14.55M | 12.25M | 10.38M | 8.92M | 11.95M | 11.66M | 8.26M | 11.31M | 11.66M | 13.60M | 18.82M | 17.48M | 22.49M | 18.27M | 20.88M | 21.22M | 14.68M | 13.76M | 19.19M | 21.21M | 4.50M | 10.65M | 21.10M |
| Diluted EPS | 0.13 | 0.03 | 0.02 | 0.13 | -0.88 | 0.10 | 0.56 | 0.19 | 0.18 | 0.05 | 0.14 | 0.21 | 0.98 | 0.16 | 0.00 | 0.18 | 0.32 | 0.60 | 0.35 | 0.29 | 0.25 | 0.34 | 0.33 | 0.23 | 0.32 | 0.33 | 0.38 | 0.53 | 0.49 | 0.63 | 0.51 | 0.58 | 0.59 | 0.41 | 0.38 | 0.53 | 0.59 | 0.12 | 0.30 | 0.51 |
| R&D Expense | 5.83M | 5.86M | 7.53M | 7.74M | 7.84M | 8.21M | 7.84M | 7.69M | 7.29M | 8.05M | 8.02M | 7.96M | 9.21M | 9.00M | 11.66M | 11.99M | 12.55M | 13.20M | 14.00M | 13.39M | 13.81M | 15.33M | 14.44M | 15.23M | 18.68M | 16.95M | 17.47M | 20.93M | 21.59M | 21.35M | 22.83M | 23.38M | 22.02M | 23.25M | 23.73M | 23.25M | 23.24M | 25.29M | 24.09M | 23.25M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 254.39M | 285.89M | 304.30M | 243.80M | 316.91M | 364.71M | 373.60M | 384.76M | 521.29M | 614.34M | 626.10M | 590.62M | 706.79M | 860.90M | 881.66M | 949.25M | 980.60M |
| Gross Profit | 98.55M | 130.61M | 133.10M | 105.52M | 132.23M | 150.17M | 157.89M | 162.45M | 220.53M | 261.53M | 262.08M | 244.52M | 300.33M | 378.47M | 399.90M | 421.55M | 435.28M |
| Operating Income | -20.24M | 36.03M | 35.85M | 20.26M | 19.45M | -16.81M | 28.93M | 32.95M | 57.57M | 71.01M | 55.28M | 55.89M | 64.05M | 103.08M | 110.50M | 110.58M | 94.01M |
| Net Income | -71.33M | -687.00K | 28.97M | 19.54M | 7.31M | -24.25M | 35.62M | 22.00M | 60.05M | 49.11M | 40.77M | 44.52M | 50.33M | 74.05M | 72.88M | 64.09M | 53.83M |
| Diluted EPS | -4.48 | -0.03 | 0.86 | 0.58 | 0.21 | -0.70 | 1.02 | 0.63 | 1.13 | 1.43 | 1.15 | 1.25 | 1.41 | 2.06 | 2.02 | 1.77 | 1.47 |
| R&D Expense | 28.25M | 22.30M | 23.45M | 18.53M | 23.79M | 28.95M | 31.04M | 32.00M | 41.67M | 51.02M | 55.97M | 61.00M | 72.52M | 85.77M | 91.68M | 95.52M | 95.48M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 367.17M | 348.50M | 337.46M | 378.81M | 396.29M | 416.05M | 425.64M | 726.70M | 719.58M | 869.74M | 865.18M | 1.23B | 1.24B | 1.23B | 1.39B | 1.81B |
| Total Equity | 152.90M | 84.31M | 178.35M | 209.00M | 227.81M | 241.98M | 210.82M | 244.70M | 258.87M | 311.55M | 368.25M | 417.17M | 476.81M | 521.29M | 577.59M | 673.46M | 745.70M | 1.31B |
| Cash & Equivalents | 69.00M | 63.33M | 56.78M | 54.84M | 65.79M | 60.98M | 51.15M | 59.96M | 68.11M | 100.06M | 82.04M | 78.94M | 125.05M | 117.39M | 100.11M | 105.05M | 113.99M | 380.87M |
| Long Term Debt | - | - | 107.58M | 58.00M | 42.50M | 64.00M | 105.03M | 88.43M | 70.55M | 225.50M | 202.84M | 215.33M | 194.93M | 429.36M | 430.66M | 349.40M | 411.95M | 212.54M |
| Total Liabilities | - | - | 188.49M | 139.14M | 109.25M | 136.40M | 185.04M | 171.34M | 166.77M | 368.24M | 351.32M | 452.56M | 388.37M | 706.59M | 663.63M | 552.60M | 642.81M | 492.82M |
| Current Liabilities | - | - | 59.26M | 59.06M | 54.93M | 61.49M | 54.06M | 56.95M | 70.50M | 98.17M | 104.20M | 134.85M | 114.23M | 183.94M | 164.52M | 139.18M | 167.79M | 212.37M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -25.79M | -4.74M | 45.17M | 28.43M | 49.20M | 42.29M | 33.42M | 47.79M | 63.38M | 89.65M | 63.25M | 140.24M | 94.62M | 90.78M | 120.08M | 158.51M | 64.06M |
| Investing Cash Flow | 19.71M | 8.75M | -4.22M | 2.98M | -72.96M | -89.77M | -1.63M | -12.87M | -177.38M | -45.59M | -63.84M | -13.16M | -306.70M | -42.54M | -19.89M | -208.19M | -74.32M |
| Financing Cash Flow | - | -11.56M | -43.09M | -21.11M | 18.57M | 40.28M | -21.54M | -23.19M | 143.33M | -60.16M | -3.94M | -84.36M | 204.75M | -60.15M | -97.85M | 56.94M | 276.33M |
| Capital Expenditure | -1.32M | -2.66M | -4.22M | -3.52M | -4.78M | -5.42M | -5.55M | -8.46M | -9.09M | -14.66M | -10.74M | -10.52M | -19.98M | -19.64M | -19.96M | -17.16M | -15.63M |
| Free Cash Flow | -27.11M | -7.40M | 40.96M | 24.91M | 44.42M | 36.87M | 27.86M | 39.33M | 54.28M | 74.99M | 52.51M | 129.72M | 74.65M | 71.14M | 100.11M | 141.35M | 48.43M |
| Share Buybacks | - | - | - | - | 526.00K | - | 1.63M | 1.63M | 370.00K | 5.85M | 10.00M | 5.50M | - | 10.00M | - | - | 39.28M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 38.7% | 45.7% | 43.7% | 43.3% | 41.7% | 41.2% | 42.3% | 42.2% | 42.3% | 42.6% | 41.9% | 41.4% | 42.5% | 44.0% | 45.4% | 44.4% | 44.4% |
| Operating Margin % | -8.0% | 12.6% | 11.8% | 8.3% | 6.1% | -4.6% | 7.7% | 8.6% | 11.0% | 11.6% | 8.8% | 9.5% | 9.1% | 12.0% | 12.5% | 11.6% | 9.6% |
| Net Margin % | -28.0% | -0.2% | 9.5% | 8.0% | 2.3% | -6.6% | 9.5% | 5.7% | 11.5% | 8.0% | 6.5% | 7.5% | 7.1% | 8.6% | 8.3% | 6.8% | 5.5% |
| ROE % | -84.6% | -0.4% | 13.9% | 8.6% | 3.0% | -11.5% | 14.6% | 8.5% | 19.3% | 13.3% | 9.8% | 9.3% | 9.7% | 12.8% | 10.8% | 8.6% | 4.1% |
| ROCE % | - | 11.7% | 12.4% | 7.2% | 6.1% | -4.9% | 8.1% | 9.3% | 9.2% | 11.5% | 7.5% | 7.4% | 6.1% | 9.6% | 10.2% | 9.1% | 5.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 12.33% | 4.65M | $774.90M |
| 2 | Vanguard Portfolio Management LLC | 6.56% | 2.48M | $412.33M |
| 3 | Price (T.Rowe) Associates Inc | 4.73% | 1.78M | $297.05M |
| 4 | Allspring Global Investments Holdings, LLC | 4.71% | 1.78M | $295.77M |
| 5 | Vanguard Capital Management LLC | 4.27% | 1.61M | $268.55M |
| 6 | Conestoga Capital Advisors, LLC | 3.84% | 1.45M | $241.35M |
| 7 | State Street Corporation | 3.55% | 1.34M | $222.93M |
| 8 | Wasatch Advisors LP | 2.64% | 996.64K | $165.91M |
| 9 | Geode Capital Management, LLC | 2.48% | 936.97K | $155.98M |
| 10 | Geneva Capital Management LLC | 2.47% | 931.27K | $155.03M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NOVT
Novanta schedules its second-quarter results call for Aug. 6 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQVm41cTY1SDktRE9CdVJuUjJ1VHhrNmRTSE1FQzFSNm1DS0xrb29heS0wQTNKRU8xYTBNaEQySktZTFQ4OGstUXowMDVmdUJXa0F0QUFrMVJLTzhYeXVsdERfVzZBd1ktYVh5VTBraVo3VV94VTEyTGFXUVo3SkoxY2lmcGNmTmYtU2I4OE…
Novanta (NOVT) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPcFZBUmI5YWlKTFV5bVpucjUwMHZZekFXek1MWElCTmljejZqYnczY0M4bHljZHhnTGRYOXZIeGRnaGkzcGVSZ0pGQjRJWE5fdzFBeDdIUlR6Q3pkcWtYMXRRaEU0cUJzVEdvOWFrdGNTTnhpZ2ZJWFdjcXFzTHdqWkdpQlYyYXVvTmZfWn…
Novanta Inc (NOVT) Stock Up 3.3% but GF Value Says Overvalued -- GF Score: 88/100 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPeklyS0RjQzZ1bjdQNlh0WGNnWkY4Sk1FeVFnWVEwT3lZUFhLXzB6UU9UN21EbGY2MldBRGxsMmFBZzE2R1d2aGhDbWUyVF9GZjMwbnJrM3BkN1B5NGZEXy1McjRXemo3OHNmVDJEVU5DMUtUazdObkdpLUh3bUN2RW1LUDNGNmpXY1JmN0…
NOVT Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE1jS3dhTVVXbGgtYW9EY1NXOGJDMENXTTRrUDdKOE1ydjQ0ckpFZHNLNzJsTVI4dll2OXBBSWYwLThqZUVlekFVTERqRVd4WWxYYm5rWGEzSldhdmxLbkl4bjBDc2FsNW1rRnliRzB5SklvSlZ4WWV4MUhn?oc=5" target="_blank">NOV…
NOVT Q1 2026 Earnings: EPS Beats Estimates, Stock Declines Amid Revenue Uncertainty - Interim Report - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPYjhhbFFrYjktR3hETW92aldkLUw5X0lXRklCZUxUblRMUkk0UE9yYzdkQy1RMUF3QXpUQ2c1UXRsMWNWWkV5NW9MOGxvMG9DOFhjT2xfMmRuaExONFppcUpOSmZxMHhvN3lzTW5LaVdZaGdPMkFISkVmczA1Q0dqNno4ckNjVHJzM0FQRT…
Novanta Inc. (NOVT) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQRTR5YnNNYVpQcWttelVwUHZBVFVkQWIwajJaZGNmNkFuVHI2T2tVQk42Sjl6eU1WdWVFYzc0RzlOWkJZRkIydm9PcjFCLThuVEVfSHNEVm5Nd3ZHUE1VeVBkb1lIcXI4RWw1MUdVcW1rYXFrdU1va2xYbk16THotMnllenl3Y09NeUx0LW…
NOVT — Frequently Asked Questions
What is the current share price of Novanta Inc. (NOVT)?
As of 2026-07-14 21:23 PDT, Novanta Inc. (NOVT) trades at $146.62 on NasdaqGS. Its 52-week range is $99.22 to $168.59.
What is the market capitalisation of NOVT?
Novanta Inc. (NOVT) has a market capitalisation of $5.22B on NasdaqGS.
What is the P/E ratio of NOVT?
NOVT trades at a trailing price-to-earnings (P/E) ratio of 104.73. The industry average P/E is 36.02. Its price-to-book (P/B) ratio is 4.36.
What is the return on equity (ROE) of NOVT?
NOVT has a return on equity (ROE) of 5.16%. Its return on capital employed (ROCE) is 5.90%.
Is NOVT a good stock to buy?
This page provides a data-driven analysis of Novanta Inc. (NOVT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.